Jiangzhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000M80
CNY
23.19
0.19 (0.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 12.39% and Operating profit at 11.78% over the last 5 years

 
2

Negative results in Mar 25

3

With ROE of 22.88%, it has a very attractive valuation with a 3.42 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 13,509 Million (Large Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

5.59%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

22.88%

stock-summary
Price to Book

3.42

Revenue and Profits:
Net Sales:
942 Million
(Quarterly Results - Jun 2025)
Net Profit:
253 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.82%
0%
6.82%
6 Months
-1.53%
0%
-1.53%
1 Year
12.41%
0%
12.41%
2 Years
4.27%
0%
4.27%
3 Years
49.81%
0%
49.81%
4 Years
90.39%
0%
90.39%
5 Years
103.96%
0%
103.96%

Jiangzhong Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.39%
EBIT Growth (5y)
11.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.05
Tax Ratio
15.82%
Dividend Payout Ratio
95.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.69%
ROE (avg)
16.29%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.42
EV to EBIT
12.82
EV to EBITDA
11.11
EV to Capital Employed
4.68
EV to Sales
2.80
PEG Ratio
1.20
Dividend Yield
5.59%
ROCE (Latest)
36.47%
ROE (Latest)
22.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -19.24% vs -19.24% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -17.61% vs 73.67% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "942.10",
          "val2": "1,166.60",
          "chgp": "-19.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "331.50",
          "val2": "345.40",
          "chgp": "-4.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "252.70",
          "val2": "306.70",
          "chgp": "-17.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "312.60%",
          "val2": "264.30%",
          "chgp": "4.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.64% vs 17.37% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.34% vs 21.75% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,371.20",
          "val2": "4,489.70",
          "chgp": "-2.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,035.00",
          "val2": "966.00",
          "chgp": "7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "7.90",
          "chgp": "-72.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.80",
          "val2": "-30.40",
          "chgp": "80.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "860.50",
          "val2": "787.00",
          "chgp": "9.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "205.30%",
          "val2": "186.90%",
          "chgp": "1.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
942.10
1,166.60
-19.24%
Operating Profit (PBDIT) excl Other Income
331.50
345.40
-4.02%
Interest
0.30
0.20
50.00%
Exceptional Items
0.60
0.00
Consolidate Net Profit
252.70
306.70
-17.61%
Operating Profit Margin (Excl OI)
312.60%
264.30%
4.83%
USD in Million.
Net Sales

QoQ Growth in quarter ended Jun 2025 is -19.24% vs -19.24% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -17.61% vs 73.67% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,371.20
4,489.70
-2.64%
Operating Profit (PBDIT) excl Other Income
1,035.00
966.00
7.14%
Interest
2.20
7.90
-72.15%
Exceptional Items
-5.80
-30.40
80.92%
Consolidate Net Profit
860.50
787.00
9.34%
Operating Profit Margin (Excl OI)
205.30%
186.90%
1.84%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.64% vs 17.37% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 9.34% vs 21.75% in Dec 2023

stock-summaryCompany CV
About Jiangzhong Pharmaceutical Co., Ltd. stock-summary
stock-summary
Jiangzhong Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available